FDAClass IIJuly 30, 2025

Epinephrine Lidocaine HCL recall: Subpotent

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852…

Why was Epinephrine Lidocaine HCL recalled?

Sub-Potent Drug: Subpotent assay results during stability testing.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 24DEC017, Exp. 07/12/2025.

Product
Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852…
Recalling firm
Imprimis NJOF, LLC
Quantity
6,880 vials
Distribution
Nationwide in the USA
Recall date
July 30, 2025
Classification
Class II
Status
Completed
Agency
FDA (drug)
Open FDA enforcement record Latest recalls